Moving to the results of the KM plotter, breast, gastric, and liver tumors demonstrated a negative correlation between ECT2 expression and patient survival in all of the analyzed models (Figure 4A,D,E), while ovarian cancer showed the same correlation in terms of overall and progress-free survival (Figure 4B). The gene discussed is ECT2; the disease is ovarian carcinoma.